# Ovarian Cancer — Fifth Annual National General Medical Oncology Summit Page: https://stenobird.com/podcast/gynecologic-oncology-update-612940/ovarian-cancer-fifth-annual-national-general-medical-oncology-summit Text version: https://stenobird.com/podcast/gynecologic-oncology-update-612940/ovarian-cancer-fifth-annual-national-general-medical-oncology-summit.md Podcast: [Gynecologic Oncology Update](https://stenobird.com/podcast/gynecologic-oncology-update-612940) Published: 2026-06-19T21:00:00+00:00 Episode link: https://gynecologic-oncology.captivate.fm/episode/6009-gmo26-ovarian Audio file: https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/ac8882b0-37fc-4533-a514-48f43ae0a514.mp3 Processing state: not_requested JSON: https://stenobird.com/v1/public/podcasts/gynecologic-oncology-update-612940/episodes/ovarian-cancer-fifth-annual-national-general-medical-oncology-summit Duration seconds: 3268 ## Resource Featuring perspectives from Dr Deborah K Armstrong and Dr David M O’Malley, including the following topics: Introduction (0:00) PARP Inhibitors and Strategies Targeting Folate Receptor Alpha in Advanced Ovarian Cancer — Dr Armstrong (4:37) Other Novel Agents and Strategies for the Treatment of Advanced Ovarian Cancer — Dr O’Malley (35:18) CME information and select publications ## Actions - request_transcript: `POST https://stenobird.com/v1/public/podcasts/gynecologic-oncology-update-612940/episodes/ovarian-cancer-fifth-annual-national-general-medical-oncology-summit/transcription-requests` — Idempotently request low-priority transcript generation for this episode. - read_markdown: `GET https://stenobird.com/podcast/gynecologic-oncology-update-612940/ovarian-cancer-fifth-annual-national-general-medical-oncology-summit.md` — Read the agent-friendly Markdown representation of this episode resource. A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed. ## Transcript Full transcripts are not published on public pages unless there is a clear rights basis.